+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Radiation Dose Management - Global Strategic Business Report

  • PDF Icon

    Report

  • 179 Pages
  • December 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 4805408
The global market for Radiation Dose Management was estimated at US$341.1 Million in 2023 and is projected to reach US$835.2 Million by 2030, growing at a CAGR of 13.6% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Radiation Dose Management Market - Key Trends and Drivers Summarized

Radiation Dose Management: Ensuring Patient Safety in Medical Imaging

Radiation dose management refers to the systematic approach to monitoring, controlling, and optimizing the amount of radiation exposure patients receive during medical imaging procedures such as X-rays, CT scans, and nuclear medicine. This process is crucial in ensuring patient safety while achieving the diagnostic quality necessary for accurate medical evaluations. Excessive radiation exposure can increase the risk of adverse health effects, including cancer, making it essential to minimize exposure while maintaining the integrity of the diagnostic information. Radiation dose management systems are designed to track radiation doses, alert healthcare providers to potentially excessive exposure levels, and implement best practices to optimize radiation use. The implementation of these systems is becoming increasingly important as the use of diagnostic imaging continues to grow worldwide.

How Are Technological Advancements Enhancing Radiation Dose Management?

Technological advancements have significantly improved radiation dose management systems, making them more efficient, precise, and integrated into healthcare workflows. Modern systems now incorporate advanced analytics and machine learning algorithms that analyze radiation dose data in real-time, providing immediate feedback to healthcare providers. These systems can automatically adjust imaging protocols based on patient size, age, and the specific diagnostic requirement, thereby minimizing unnecessary exposure without compromising image quality. The integration of radiation dose management systems with electronic health records (EHRs) allows for seamless documentation and tracking of patient radiation histories, enabling more personalized and informed decisions about future imaging procedures. Additionally, advancements in dose optimization software have made it possible to standardize protocols across different imaging devices, ensuring consistency in radiation management across a healthcare facility. These technological improvements are driving the adoption of sophisticated radiation dose management systems, enhancing patient safety and improving outcomes in medical imaging.

What Are the Key Applications and Benefits of Radiation Dose Management in Medical Imaging?

Radiation dose management systems are utilized across various imaging modalities, offering numerous benefits that enhance patient safety, compliance with regulatory standards, and overall healthcare quality. In diagnostic radiology, these systems help monitor and reduce radiation exposure during CT scans, which are known for their relatively high radiation doses compared to other imaging techniques. In interventional radiology, where procedures often involve prolonged exposure times, radiation dose management is critical for protecting both patients and healthcare staff from excessive radiation. The systems are also valuable in pediatric imaging, where minimizing radiation exposure is particularly important due to the increased sensitivity of children to radiation. Furthermore, radiation dose management systems support compliance with international standards and regulations, such as those set by the International Atomic Energy Agency (IAEA) and the European Atomic Energy Community (Euratom), ensuring that healthcare providers meet safety requirements. The primary benefits of radiation dose management include enhanced patient safety, improved clinical decision-making, and reduced risk of radiation-induced complications, making it an essential component of modern medical imaging practices.

What Factors Are Driving the Growth in the Radiation Dose Management Market?

The growth in the Radiation Dose Management market is driven by several factors. The increasing awareness of radiation safety among healthcare providers and patients is a significant driver, as more emphasis is placed on minimizing radiation exposure during medical imaging. Technological advancements in dose management software, data analytics, and machine learning are also propelling market growth by improving the precision and efficiency of these systems. The rising number of diagnostic imaging procedures worldwide, particularly in aging populations, is further boosting demand for radiation dose management solutions, as these systems are essential for ensuring patient safety in high-volume imaging environments. Additionally, stringent regulatory requirements and accreditation standards related to radiation safety are contributing to market growth, as healthcare providers seek to comply with these regulations by implementing advanced dose management systems. The growing adoption of electronic health records (EHRs) and the integration of dose management systems with EHRs are also supporting market expansion, as these technologies enable better tracking and optimization of radiation exposure. These factors, combined with continuous innovation in healthcare technology, are driving the sustained growth of the Radiation Dose Management market.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Radiation Dose Management Solutions segment, which is expected to reach US$479.6 Million by 2030 with a CAGR of a 14.0%. The Radiation Dose Management Services segment is also set to grow at 13.2% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $92.0 Million in 2023, and China, forecasted to grow at an impressive 12.7% CAGR to reach $126.3 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Radiation Dose Management Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Radiation Dose Management Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Radiation Dose Management Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Agfa HealthCare, Bayer AG, Bracco Imaging SpA, and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 11 Featured):

  • Agfa HealthCare
  • Bayer AG
  • Bracco Imaging SpA
  • FUJIFILM Holdings Corporation
  • GE Healthcare
  • Medsquare
  • Novarad Corporation
  • PACSHealth LLC
  • Philips Healthcare
  • Qaelum N.V.
  • Sectra AB
  • Siemens Healthineers

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Radiation Dose Management - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • Global Economic Update
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Focus on Patient Safety and Radiation Protection Propels Market Growth
  • Technological Advancements in Dose Tracking and Monitoring Software Strengthen Market Position
  • Growing Adoption of Digital Health Records Drives Integration of Dose Management Systems
  • Surge in Demand for Dose Management Solutions in Diagnostic Imaging Generates New Opportunities
  • Development of AI and Machine Learning-Based Dose Optimization Sustains Market Growth
  • Expanding Applications in Interventional Radiology Throws Spotlight on Market Potential
  • Growth in Radiology Practices and Imaging Centers Spurs Demand for Dose Management
  • Increasing Awareness of Radiation-Induced Health Risks Strengthens Business Case
  • Rising Adoption of Cloud-Based Dose Management Solutions Propels Market Expansion
  • Surge in Demand for Automated Dose Monitoring in Radiation Therapy Expands Market Horizons
  • Growing Emphasis on Compliance with International Radiation Safety Standards Drives Market Adoption
  • Innovations in Real-Time Dose Monitoring and Reporting Generate New Market Opportunities
  • Rising Demand for Dose Management in Pediatric and Geriatric Imaging Throws Spotlight on Market Dynamics
4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Computed Tomography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 2: World 7-Year Perspective for Computed Tomography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • TABLE 3: World Recent Past, Current & Future Analysis for Radiography & Mammography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 4: World 7-Year Perspective for Radiography & Mammography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Nuclear Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 6: World 7-Year Perspective for Nuclear Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 8: World 7-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • TABLE 9: World Recent Past, Current & Future Analysis for Ambulatory Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 10: World 7-Year Perspective for Ambulatory Care Settings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • TABLE 11: World Radiation Dose Management Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • TABLE 12: World Recent Past, Current & Future Analysis for Radiation Dose Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 13: World 7-Year Perspective for Radiation Dose Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Solutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 15: World 7-Year Perspective for Solutions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 17: World 7-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • TABLE 18: World Recent Past, Current & Future Analysis for Fluoroscopy & Interventional Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 19: World 7-Year Perspective for Fluoroscopy & Interventional Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 21: World 7-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Radiation Dose Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 22: USA Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 23: USA 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
  • TABLE 24: USA Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 25: USA 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
  • TABLE 26: USA Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 27: USA 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
CANADA
  • TABLE 28: Canada Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 29: Canada 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
  • TABLE 30: Canada Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 31: Canada 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
  • TABLE 32: Canada Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 33: Canada 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
JAPAN
  • Radiation Dose Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 34: Japan Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 35: Japan 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
  • TABLE 36: Japan Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 37: Japan 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
  • TABLE 38: Japan Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 39: Japan 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
CHINA
  • Radiation Dose Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 40: China Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 41: China 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
  • TABLE 42: China Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 43: China 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
  • TABLE 44: China Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 45: China 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
EUROPE
  • Radiation Dose Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 46: Europe Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 47: Europe 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
  • TABLE 48: Europe Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 49: Europe 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
  • TABLE 50: Europe Recent Past, Current & Future Analysis for Radiation Dose Management by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 51: Europe 7-Year Perspective for Radiation Dose Management by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
  • TABLE 52: Europe Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 53: Europe 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
FRANCE
  • Radiation Dose Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 54: France Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 55: France 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
  • TABLE 56: France Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 57: France 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
  • TABLE 58: France Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 59: France 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
GERMANY
  • Radiation Dose Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 60: Germany Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 61: Germany 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
  • TABLE 62: Germany Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 63: Germany 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
  • TABLE 64: Germany Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 65: Germany 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
ITALY
  • TABLE 66: Italy Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 67: Italy 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
  • TABLE 68: Italy Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 69: Italy 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
  • TABLE 70: Italy Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 71: Italy 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
UNITED KINGDOM
  • Radiation Dose Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 72: UK Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 73: UK 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
  • TABLE 74: UK Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 75: UK 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
  • TABLE 76: UK Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 77: UK 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
REST OF EUROPE
  • TABLE 78: Rest of Europe Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 79: Rest of Europe 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
  • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 81: Rest of Europe 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
  • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 83: Rest of Europe 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
ASIA-PACIFIC
  • Radiation Dose Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 84: Asia-Pacific Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 85: Asia-Pacific 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
  • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 87: Asia-Pacific 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
  • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 89: Asia-Pacific 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
REST OF WORLD
  • TABLE 90: Rest of World Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 91: Rest of World 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
  • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 93: Rest of World 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
  • TABLE 94: Rest of World Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 95: Rest of World 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
IV. COMPETITION

Companies Mentioned

  • Agfa HealthCare
  • Bayer AG
  • Bracco Imaging SpA
  • FUJIFILM Holdings Corporation
  • GE Healthcare
  • Medsquare
  • Novarad Corporation
  • PACSHealth LLC
  • Philips Healthcare
  • Qaelum N.V.
  • Sectra AB
  • Siemens Healthineers

Table Information